underrepresented aml clinical trial groups | what solutions are underway?
Published 3 months ago • 10 plays • Length 3:42Download video MP4
Download video MP3
Similar videos
-
4:16
what aml clinical trial inequities do minority and ethnic groups face?
-
3:00
aml diagnosis disparities | factors impacting underrepresented racial and ethnic groups
-
4:07
aml clinical trials critical to treatment breakthroughs and improvements
-
2:28
where do clinical trials fit into an aml treatment plan?
-
3:16
advances in aml research | where do clinical trials fit in?
-
4:13
a look at ongoing acute myeloid leukemia phase iii trials
-
53:48
emerging research and promising aml treatment approaches
-
5:46
the truth about clinical trials in aml
-
22:11
empowered aml patient ask the aml expert
-
6:52
what are key acute myeloid leukemia care barriers and solutions?
-
1:58
when should aml patients consider joining a clinical trial?
-
2:41
how can underrepresented mpn communities access support?
-
2:49
what aml treatment options are available for mrd-positive patients?
-
1:16
are clinical trial participants monitored more closely?
-
2:11
assessing untreated aml patients who are ineligible for intensive chemotherapy
-
1:36
how has telemedicine impacted head and neck cancer clinical trials
-
3:43
understanding clinical trial phases
-
2:42
which tests do you need before deciding on an aml treatment path?
-
2:40
know aml | acute myeloid leukemia clinical trials